Nomura Holdings’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Nomura Holdings’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-37,970	Closed	-$204K	–	1703
2016 Q1	$204K	Buy	+37,970	New	+$232K	﹤0.01%	1240
2015 Q4	–	Sell	-30,704	Closed	-$264K	–	2151
2015 Q3	$264K	Buy	30,704 +4,773	+18%	+$44K	﹤0.01%	1247
2015 Q2	$289K	Sell	25,931 -13,915	-35%	-$179K	﹤0.01%	1470
2015 Q1	$562K	Buy	39,846 +3,218	+9%	+$49.2K	﹤0.01%	1033
2014 Q4	$620K	Buy	36,628 +8,628	+31%	+$126K	﹤0.01%	1544
2014 Q3	$377K	Buy	28,000 +10,754	+62%	+$128K	﹤0.01%	2023
2014 Q2	$220K	Buy	17,246 +2,823	+20%	+$29.4K	﹤0.01%	2325
2014 Q1	$172K	Buy	+14,423	New	+$194K	﹤0.01%	2385

Other funds holding INFI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nomura Holdings's INFI Position: Q2 2016 in Review

Nomura Holdings sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2016, closing a stake of 37,970 shares — an estimated $204K sold.

Nomura Holdings first reported a position in INFI in Q1 2014 and held it in 8 quarters. The position peaked at $620K in Q4 2014. 107 funds tracked by Wall St. Rank hold INFI as of Q2 2016.

Nomura Holdings reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
Nomura Holdings sold 37,970 Infinity Pharmaceuticals, Inc. shares in Q2 2016, an estimated $204K.
Nomura Holdings first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2014 and held it in 8 quarters.
Nomura Holdings's Infinity Pharmaceuticals, Inc. position peaked at $620K in Q4 2014.
107 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2016.

Based on Nomura Holdings's 13F filing for Q2 2016, filed 15 Aug 2016.